The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2024
Filed:
May. 18, 2021
Vertex Pharmaceuticals Incorporated, Boston, MA (US);
Jeremy J. Clemens, San Diego, CA (US);
Alexander Russell Abela, Escondido, CA (US);
Corey Don Anderson, San Diego, CA (US);
Brett B. Busch, San Diego, CA (US);
Weichao George Chen, San Diego, CA (US);
Thomas Cleveland, San Marcos, CA (US);
Timothy Richard Coon, Carlsbad, CA (US);
Bryan Frieman, La Jolla, CA (US);
Senait G. Ghirmai, San Diego, CA (US);
Peter Grootenhuis, Del Mar, CA (US);
Anton V. Gulevich, San Diego, CA (US);
Sara Sabina Hadida Ruah, La Jolla, CA (US);
Clara Kuang-Ju Hsia, San Diego, CA (US);
Ping Kang, San Diego, CA (US);
Haripada Khatuya, San Diego, CA (US);
Jason McCartney, Cardiff by the Sea, CA (US);
Mark Thomas Miller, San Diego, CA (US);
Prasuna Paraselli, San Diego, CA (US);
Fabrice Pierre, La Jolla, CA (US);
Sara E. Swift, San Diego, CA (US);
Andreas Termin, Encinitas, CA (US);
Johnny Uy, San Diego, CA (US);
Carl V. Vogel, Carlsbad, CA (US);
Jinglan Zhou, San Diego, CA (US);
Vertex Pharmaceuticals Incorporated, Boston, MA (US);
Abstract
Compounds of Formula (I): pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.